Proteochemometric Modeling of the Susceptibility of Mutated Variants of the HIV-1 Virus to Reverse Transcriptase Inhibitors
暂无分享,去创建一个
Ola Spjuth | Martin Eklund | Maris Lapins | Muhammad Junaid | Jarl E. S. Wikberg | O. Spjuth | M. Lapins | J. Wikberg | M. Junaid | M. Eklund
[1] Hugo Kubinyi,et al. Chemogenomics in Drug Discovery: A Medicinal Chemistry Perspective , 2004 .
[2] T. Lundstedt,et al. PLS modeling of chimeric MS04/MSH-peptide and MC1/MC3-receptor interactions reveals a novel method for the analysis of ligand-receptor interactions. , 2001, Biochimica et biophysica acta.
[3] Ram Samudrala,et al. Antivirogram or Phenosense: A Comparison of their Reproducibility and an Analysis of their Correlation , 2003, Antiviral therapy.
[4] Bradley J. Betts,et al. Human immunodeficiency virus reverse transcriptase and protease sequence database. , 2003, Nucleic acids research.
[5] Erik Johansson,et al. Multivariate design and modeling in QSAR , 1996 .
[6] H. Marais,et al. Epidemic up Date Aids Aids Epidemic Update Special Report on Hiv Prevention , 2005 .
[7] R. Goody,et al. Factors contributing to the inhibition of HIV reverse transcriptase by chain‐terminating nucleotides in vitro and in vivo , 1991, FEBS letters.
[8] E. Clercq. Strategies in the design of antiviral drugs , 2010, Nature Reviews Drug Discovery.
[9] S. Wold,et al. Orthogonal projections to latent structures (O‐PLS) , 2002 .
[10] Thomas Lengauer,et al. Predicting the response to combination antiretroviral therapy: retrospective validation of geno2pheno-THEO on a large clinical database. , 2009, The Journal of infectious diseases.
[11] J. J. Henning,et al. Guidelines for the Use of Antiretroviral Agents in HIV-Infected Adults and Adolescents, January 28, 2000 , 1998, HIV clinical trials.
[12] T. Lundstedt,et al. Proteochemometrics modeling of the interaction of amine G-protein coupled receptors with a diverse set of ligands. , 2002, Molecular pharmacology.
[13] P. Campbell. Functions of polyribosomes attached to membranes of animal cells , 1970, FEBS letters.
[14] Thomas B. Kepler,et al. Unselected Mutations in the Human Immunodeficiency Virus Type 1 Genome Are Mostly Nonsynonymous and Often Deleterious , 2004, Journal of Virology.
[15] Thomas Lengauer,et al. Selecting anti-HIV therapies based on a variety of genomic and clinical factors , 2008, ISMB.
[16] D. Stammers,et al. HIV reverse transcriptase structures: designing new inhibitors and understanding mechanisms of drug resistance. , 2005, Trends in pharmacological sciences.
[17] Peteris Prusis,et al. QSAR and proteo-chemometric analysis of the interaction of a series of organic compounds with melanocortin receptor subtypes. , 2003, Journal of medicinal chemistry.
[18] Peteris Prusis,et al. Proteochemometric Mapping of the Interaction of Organic Compounds with Melanocortin Receptor Subtypes , 2005, Molecular Pharmacology.
[19] S. Wold,et al. New chemical descriptors relevant for the design of biologically active peptides. A multivariate characterization of 87 amino acids. , 1998, Journal of medicinal chemistry.
[20] N. Sluis-Cremer,et al. Inhibitors of HIV-1 reverse transcriptase. , 2000, Advances in pharmacology.
[21] Peteris Prusis,et al. Proteochemometric modeling of HIV protease susceptibility , 2008, BMC Bioinformatics.
[22] JD Lundgren,et al. Prediction of phenotypic susceptibility to antiretroviral drugs using physiochemical properties of the primary enzymatic structure combined with artificial neural networks , 2008, HIV medicine.
[23] Peteris Prusis,et al. Rough set‐based proteochemometrics modeling of G‐protein‐coupled receptor‐ligand interactions , 2006, Proteins.
[24] Frederick E. Petry,et al. Principles and Applications , 1997 .
[25] R. Shafer,et al. Genotypic predictors of human immunodeficiency virus type 1 drug resistance , 2006, Proceedings of the National Academy of Sciences.
[26] Peteris Prusis,et al. Improved approach for proteochemometrics modeling: application to organic compound - amine G protein-coupled receptor interactions , 2005, Bioinform..
[27] T. Lundstedt,et al. Development of proteo-chemometrics: a novel technology for the analysis of drug-receptor interactions. , 2001, Biochimica et biophysica acta.
[28] S. Wold,et al. PLS-regression: a basic tool of chemometrics , 2001 .
[29] N. Sluis-Cremer,et al. Inhibitors of HIV- I reverse transcriptase , 2000 .
[30] Paul Geladi,et al. Principal Component Analysis , 1987, Comprehensive Chemometrics.
[31] L. Eriksson. Multi- and megavariate data analysis , 2006 .
[32] Egon L. Willighagen,et al. XMPP for cloud computing in bioinformatics supporting discovery and invocation of asynchronous web services , 2009, BMC Bioinformatics.
[33] A. Tropsha,et al. Beware of q2! , 2002, Journal of molecular graphics & modelling.
[34] S. Goff,et al. Retroviral reverse transcriptase: synthesis, structure, and function. , 1990, Journal of acquired immune deficiency syndromes.
[35] P. Prusis,et al. Proteochemometric modelling of antibody-antigen interactions using SPOT synthesised peptide arrays. , 2007, Protein engineering, design & selection : PEDS.
[36] Roberto Todeschini,et al. Handbook of Molecular Descriptors , 2002 .
[37] Takeaki Uno,et al. Mining complex genotypic features for predicting HIV-1 drug resistance , 2007, Bioinform..
[38] Peteris Prusis,et al. A Look Inside HIV Resistance through Retroviral Protease Interaction Maps , 2007, PLoS Comput. Biol..
[39] J. Coffin,et al. HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy , 1995, Science.
[40] Thomas Lengauer,et al. Data and text mining Computational methods for the design of effective therapies against drug resistant HIV strains , 2005 .
[41] Peteris Prusis,et al. Proteochemometrics: A Tool for Modeling the Molecular Interaction Space , 2005 .
[42] Thomas Lengauer,et al. Geno2pheno: estimating phenotypic drug resistance from HIV-1 genotypes , 2003, Nucleic Acids Res..
[43] B. Clotet,et al. Thymidine Analogue Mutation Profiles: Factors Associated with Acquiring Specific Profiles and their Impact on the Virological Response to Therapy , 2005, Antiviral therapy.